Article Text

Download PDFPDF
Driving after pupil dilation and insurance claims
  1. Timothy A de Klerk,
  2. Dong Y Park,
  3. Mandagere Vishwanath
  1. Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester, UK
  1. Correspondence to Timothy A de Klerk, Department of Ophthalmology, Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UK; timothydeklerk{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

It is common practice to routinely instruct patients not to drive after being administered mydriatics with the explanation that insurance companies may not pay out in the event of a motor vehicle accident. Although there is no objective evidence to suggest that driving performance is compromised by pupil dilation, a handful of papers have shown that dilatation has a small but significant effect on visual acuity, contrast sensitivity and glare sensitivity.1–3 It is possible that in the minority of patients, this may result in the vision dropping below the legal requirements set by the Driver and Vehicle Licensing Agency (DVLA), UK.2

Keightley quoted personal communications with the Association of British Insurers (ABI) suggesting that insurers would have …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.